85 related articles for article (PubMed ID: 15883006)
1. Inhibition of beta-catenin-mediated transactivation by flavanone in AGS gastric cancer cells.
Park CH; Hahm ER; Lee JH; Jung KC; Yang CH
Biochem Biophys Res Commun; 2005 Jun; 331(4):1222-8. PubMed ID: 15883006
[TBL] [Abstract][Full Text] [Related]
2. Negative regulation of beta-catenin/Tcf signaling by naringenin in AGS gastric cancer cell.
Lee JH; Park CH; Jung KC; Rhee HS; Yang CH
Biochem Biophys Res Commun; 2005 Sep; 335(3):771-6. PubMed ID: 16102728
[TBL] [Abstract][Full Text] [Related]
3. The inhibitory mechanism of curcumin and its derivative against beta-catenin/Tcf signaling.
Park CH; Hahm ER; Park S; Kim HK; Yang CH
FEBS Lett; 2005 May; 579(13):2965-71. PubMed ID: 15893313
[TBL] [Abstract][Full Text] [Related]
4. Quercetin, a potent inhibitor against beta-catenin/Tcf signaling in SW480 colon cancer cells.
Park CH; Chang JY; Hahm ER; Park S; Kim HK; Yang CH
Biochem Biophys Res Commun; 2005 Mar; 328(1):227-34. PubMed ID: 15670774
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide-donating aspirin inhibits beta-catenin/T cell factor (TCF) signaling in SW480 colon cancer cells by disrupting the nuclear beta-catenin-TCF association.
Nath N; Kashfi K; Chen J; Rigas B
Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12584-9. PubMed ID: 14566053
[TBL] [Abstract][Full Text] [Related]
6. Cross-talk between Rac1 GTPase and dysregulated Wnt signaling pathway leads to cellular redistribution of beta-catenin and TCF/LEF-mediated transcriptional activation.
Esufali S; Bapat B
Oncogene; 2004 Oct; 23(50):8260-71. PubMed ID: 15377999
[TBL] [Abstract][Full Text] [Related]
7. Ionomycin downregulates beta-catenin/Tcf signaling in colon cancer cell line.
Park CH; Hahm ER; Lee JH; Jung KC; Rhee HS; Yang CH
Carcinogenesis; 2005 Nov; 26(11):1929-33. PubMed ID: 15930030
[TBL] [Abstract][Full Text] [Related]
8. The nonsteroidal anti-inflammatory drugs aspirin and indomethacin attenuate beta-catenin/TCF-4 signaling.
Dihlmann S; Siermann A; von Knebel Doeberitz M
Oncogene; 2001 Feb; 20(5):645-53. PubMed ID: 11313997
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of beta-catenin/Tcf signaling by flavonoids.
Park S; Choi J
J Cell Biochem; 2010 Aug; 110(6):1376-85. PubMed ID: 20564233
[TBL] [Abstract][Full Text] [Related]
10. TIP49 regulates beta-catenin-mediated neoplastic transformation and T-cell factor target gene induction via effects on chromatin remodeling.
Feng Y; Lee N; Fearon ER
Cancer Res; 2003 Dec; 63(24):8726-34. PubMed ID: 14695187
[TBL] [Abstract][Full Text] [Related]
11. Ligand-dependent inhibition of beta-catenin/TCF signaling by androgen receptor.
Chesire DR; Isaacs WB
Oncogene; 2002 Dec; 21(55):8453-69. PubMed ID: 12466965
[TBL] [Abstract][Full Text] [Related]
12. Streptonigrin inhibits β-Catenin/Tcf signaling and shows cytotoxicity in β-catenin-activated cells.
Park S; Chun S
Biochim Biophys Acta; 2011 Dec; 1810(12):1340-5. PubMed ID: 21763403
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of nordihydroguaiaretic acid on β-catenin/Tcf signalling in β-catenin-activated cells.
Park S; Lee J
Cell Biochem Funct; 2011; 29(1):22-9. PubMed ID: 21264886
[TBL] [Abstract][Full Text] [Related]
14. Activation of the {beta}-catenin/T-cell-specific transcription factor/lymphoid enhancer factor-1 pathway by plasminogen activators in ECV304 carcinoma cells.
Maupas-Schwalm F; Robinet C; Augé N; Thiers JC; Garcia V; Cambus JP; Salvayre R; Nègre-Salvayre A
Cancer Res; 2005 Jan; 65(2):526-32. PubMed ID: 15695395
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of beta-catenin/Tcf activity by white tea, green tea, and epigallocatechin-3-gallate (EGCG): minor contribution of H(2)O(2) at physiologically relevant EGCG concentrations.
Dashwood WM; Orner GA; Dashwood RH
Biochem Biophys Res Commun; 2002 Aug; 296(3):584-8. PubMed ID: 12176021
[TBL] [Abstract][Full Text] [Related]
16. Functional localization and competition between the androgen receptor and T-cell factor for nuclear beta-catenin: a means for inhibition of the Tcf signaling axis.
Mulholland DJ; Read JT; Rennie PS; Cox ME; Nelson CC
Oncogene; 2003 Aug; 22(36):5602-13. PubMed ID: 12944908
[TBL] [Abstract][Full Text] [Related]
17. Activation of Wnt/beta-catenin/Tcf signaling in mouse skin carcinogenesis.
Bhatia N; Spiegelman VS
Mol Carcinog; 2005 Apr; 42(4):213-21. PubMed ID: 15765534
[TBL] [Abstract][Full Text] [Related]
18. Lymphoid enhancer factor 1 makes cells resistant to transforming growth factor beta-induced repression of c-myc.
Sasaki T; Suzuki H; Yagi K; Furuhashi M; Yao R; Susa S; Noda T; Arai Y; Miyazono K; Kato M
Cancer Res; 2003 Feb; 63(4):801-6. PubMed ID: 12591729
[TBL] [Abstract][Full Text] [Related]
19. The chromatin remodelling factor Brg-1 interacts with beta-catenin to promote target gene activation.
Barker N; Hurlstone A; Musisi H; Miles A; Bienz M; Clevers H
EMBO J; 2001 Sep; 20(17):4935-43. PubMed ID: 11532957
[TBL] [Abstract][Full Text] [Related]
20. Role of a BCL9-related beta-catenin-binding protein, B9L, in tumorigenesis induced by aberrant activation of Wnt signaling.
Adachi S; Jigami T; Yasui T; Nakano T; Ohwada S; Omori Y; Sugano S; Ohkawara B; Shibuya H; Nakamura T; Akiyama T
Cancer Res; 2004 Dec; 64(23):8496-501. PubMed ID: 15574752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]